NCT06213805
Recruiting
Not Applicable
Efficacy and Safety of Minimally Invasive Micro-Sclerostomy (MIMS) in Glaucoma Surgery
Hôpital Privé de la Baie3 sites in 1 country23 target enrollmentStarted: January 15, 2024Last updated:
ConditionsGlaucoma
Overview
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Hôpital Privé de la Baie
- Enrollment
- 23
- Locations
- 3
- Primary Endpoint
- Measurement of intraocular pressure by tonometry
Overview
Brief Summary
The main objective is to evaluate the effectiveness of MIMS in patients with an indication for glaucoma surgery, compared to traditional surgery. The secondary objective is to assess safety. The investigating ophthalmologist will follow the patients and collect clinical data in order to identify the benefits and complications of MIMS. Patients are expected to experience fewer complications compared to traditional glaucoma surgery.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients ≥ 18 years old who agree to participate in the study having signed informed consent
- •Primary open-angle glaucoma, pseudoexfoliative glaucoma or pigmentary glaucoma with indication for glaucoma surgery (defined as uncontrolled intraocular pressure or worsening of visual fields, despite maximum tolerated medical therapy) and open iridocorneal angle ( trabecular meshwork visible on gonioscopy, Shaffer classification grade 3-4) and healthy and mobile conjunctiva (without scars or adhesions).
- •Chronic angle closure glaucoma with indication for combined glaucoma and cataract surgery
Exclusion Criteria
- •Presence of other ophthalmological pathologies (except cataract)
- •History of intraocular surgery (unless cataract surgery), history of trauma, or conjunctival scarring in the quadrant planned for surgery
- •Visual acuity lower than "counts fingers" ", closure of the iridocorneal angle (and angle-closure glaucoma unless associated cataract surgery), neovascular glaucoma or neovascularization of the iris, pachymetry \< 490 μm or \> 620 μm.
- •Presence of severe systemic pathologies, pregnant or breastfeeding woman
Outcomes
Primary Outcomes
Measurement of intraocular pressure by tonometry
Time Frame: day 0, day 7, day 14, day 30, month 6, month 9 and month 12 after surgery
Measure in millimeters of mercury (mmHg)
Secondary Outcomes
- Optical Coherence Tomography(month 3, month 12)
- visual quality of life VFQ-25,(month 1, month 3, month 12 after surgery)
- Visual field test(month 3, month 12)
Investigators
Study Sites (3)
Loading locations...
Similar Trials
Completed
Not Applicable
Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance StudyPrimary Open Angle GlaucomaPigmentary GlaucomaPseudoexfoliative GlaucomaNCT02355990Sanoculis Ltd96
Unknown
Not Applicable
Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Primary Angle Closure GlaucomaGlaucoma, Angle-ClosureNCT02964676Shanghai Eye Disease Prevention and Treatment Center246
Recruiting
Not Applicable
Efficacy Of Minimally Invasive Approach In The Surgical Treatment Of Complex Perianal FistulaFistula PerianalNCT06484660Hospital Son Llatzer40
Completed
Not Applicable
VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High MyopiaMyopiaRefractive ErrorsNCT02528123London Vision Clinic114
Recruiting
Not Applicable
Comparison of MIST With PRF and GBT With PRF in the Treatment of Intrabony Periodontal Defect. A Prospective RCTIntrabony Periodontal DefectNCT06768424Semmelweis University36